8th Annual USC Multidisciplinary Breast Cancer Symposium

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

8th Annual USC Multidisciplinary Breast Cancer Symposium

Videos
8th Annual USC Multidisciplinary Breast Cancer Symposium

Playback speed

10 seconds

Oncoplastic Surgery and BC: What Is Extreme Oncoplasty? When Can We Use It?

By 8th Annual USC Multidisciplinary Breast Cancer Symposium FEATURING Melvin Silverstein

58 views

February 9, 2021

Comments 1

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy

Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- …

Feat. K. Jhaveri

Videos

HR+HER2- High-Risk eBC: Surveying Efficacy Data of CDK4/6i in the Ad…

8th Annual USC Multidisciplinary Breast Cancer Symposium

G. Sledge

193 views

HR+/HER2- MBC: Outcomes of 1/2L CDK4/6 Inhibition

8th Annual USC Multidisciplinary Breast Cancer Symposium

G. Sledge

272 views

ER+ Early Stage BC: Which Patients Should Avoid Chemotherapy? Does C…

8th Annual USC Multidisciplinary Breast Cancer Symposium

G. Sledge

211 views

PI3K/AKT/mTOR Inhibition in Advanced BC: Is There Any Benefit With A…

8th Annual USC Multidisciplinary Breast Cancer Symposium

G. Sledge

74 views

Genetic Risk in BC: BRCA1/2 Mutations, Genetic Testing, Preventive B…

8th Annual USC Multidisciplinary Breast Cancer Symposium

B. Arun

28 views

Oncoplastic Surgery and BC: What Is Extreme Oncoplasty? When Can We …

8th Annual USC Multidisciplinary Breast Cancer Symposium

M. Silverstein

58 views

Diagnostic MRI for Newly Diagnosed BC: Factors of Occult Lesions Det…

8th Annual USC Multidisciplinary Breast Cancer Symposium

S. Sener

480 views

2021 Challenges in HER2+ BC Testing: IHC Guidelines, Biomarker Testi…

8th Annual USC Multidisciplinary Breast Cancer Symposium

M. Press

60 views

2021 Updates on HER2+ MBC: What Does the New Data on T-DXd Suggest? …

8th Annual USC Multidisciplinary Breast Cancer Symposium

W. Gradishar

433 views

2021 Updates on HER2+ MBC: Tucatinib Combo and HRQoL in Brain Mets, …

8th Annual USC Multidisciplinary Breast Cancer Symposium

W. Gradishar

121 views

USC Update on 1L Chemo Combination for Advanced TNBC: Does the Addit…

8th Annual USC Multidisciplinary Breast Cancer Symposium

S. Hurvitz

145 views

Innovations in Management of mTNBC: PARP Inhibitors

8th Annual USC Multidisciplinary Breast Cancer Symposium

S. Hurvitz

366 views

Clinical Trial Data on ADCs in TNBC: Sacituzumab Govitecan Efficacy …

8th Annual USC Multidisciplinary Breast Cancer Symposium

S. Hurvitz

251 views